The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells.

Bone marrow–derived mesenchymal stem cells Endothelial colony-forming cells Insulin-producing cells Pancreatic transcription factors Transdifferentiation Vasculature

Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
13 02 2019
Historique:
received: 27 11 2018
accepted: 27 01 2019
revised: 10 01 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 9 4 2020
Statut: epublish

Résumé

Insulin-dependent diabetes is a multifactorial disorder that could be theoretically cured by functional pancreatic islets and insulin-producing cell (IPC) implantation. Regenerative medicine approaches include the potential for growing tissues and organs in the laboratory and transplanting them when the body cannot heal itself. However, several obstacles remain to be overcome in order to bring regenerative medicine approach for diabetes closer to its clinical implementation; the cells generated in vitro are typically of heterogenic and immature nature and the site of implantation should be readily vascularized for the implanted cells to survive in vivo. The present study addresses these two limitations by analyzing the effect of co-implanting IPCs with vasculature promoting cells in an accessible site such as subcutaneous. Secondly, it analyzes the effects of reconstituting the in vivo environment in vitro on the maturation and function of insulin-producing cells. IPCs that are generated by the transdifferentiation of human liver cells are exposed to the paracrine effects of endothelial colony-forming cells (ECFCs) and human bone marrow mesenchymal stem cells (MSCs), which are the "building blocks" of the blood vessels. The role of the vasculature on IPC function is analyzed upon subcutaneous implantation in vivo in immune-deficient rodents. The paracrine effects of vasculature on IPC maturation are analyzed in culture. Co-implantation of MSCs and ECFCs with IPCs led to doubling the survival rates and a threefold increase in insulin production, in vivo. ECFC and MSC co-culture as well as conditioned media of co-cultures resulted in a significant increased expression of pancreatic-specific genes and an increase in glucose-regulated insulin secretion, compared with IPCs alone. Mechanistically, we demonstrate that ECFC and MSC co-culture increases the expression of CTGF and ACTIVINβα, which play a key role in pancreatic differentiation. Vasculature is an important player in generating regenerative medicine approaches for diabetes. Vasculature displays a paracrine effect on the maturation of insulin-producing cells and their survival upon implantation. The reconstitution of the in vivo niche is expected to promote the liver-to-pancreas transdifferentiation and bringing this cell therapy approach closer to its clinical implementation.

Sections du résumé

BACKGROUND
Insulin-dependent diabetes is a multifactorial disorder that could be theoretically cured by functional pancreatic islets and insulin-producing cell (IPC) implantation. Regenerative medicine approaches include the potential for growing tissues and organs in the laboratory and transplanting them when the body cannot heal itself. However, several obstacles remain to be overcome in order to bring regenerative medicine approach for diabetes closer to its clinical implementation; the cells generated in vitro are typically of heterogenic and immature nature and the site of implantation should be readily vascularized for the implanted cells to survive in vivo. The present study addresses these two limitations by analyzing the effect of co-implanting IPCs with vasculature promoting cells in an accessible site such as subcutaneous. Secondly, it analyzes the effects of reconstituting the in vivo environment in vitro on the maturation and function of insulin-producing cells.
METHODS
IPCs that are generated by the transdifferentiation of human liver cells are exposed to the paracrine effects of endothelial colony-forming cells (ECFCs) and human bone marrow mesenchymal stem cells (MSCs), which are the "building blocks" of the blood vessels. The role of the vasculature on IPC function is analyzed upon subcutaneous implantation in vivo in immune-deficient rodents. The paracrine effects of vasculature on IPC maturation are analyzed in culture.
RESULTS
Co-implantation of MSCs and ECFCs with IPCs led to doubling the survival rates and a threefold increase in insulin production, in vivo. ECFC and MSC co-culture as well as conditioned media of co-cultures resulted in a significant increased expression of pancreatic-specific genes and an increase in glucose-regulated insulin secretion, compared with IPCs alone. Mechanistically, we demonstrate that ECFC and MSC co-culture increases the expression of CTGF and ACTIVINβα, which play a key role in pancreatic differentiation.
CONCLUSIONS
Vasculature is an important player in generating regenerative medicine approaches for diabetes. Vasculature displays a paracrine effect on the maturation of insulin-producing cells and their survival upon implantation. The reconstitution of the in vivo niche is expected to promote the liver-to-pancreas transdifferentiation and bringing this cell therapy approach closer to its clinical implementation.

Identifiants

pubmed: 30760321
doi: 10.1186/s13287-019-1157-5
pii: 10.1186/s13287-019-1157-5
pmc: PMC6373031
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Références

Cell Rep. 2018 May 8;23(6):1620-1629
pubmed: 29742420
Tissue Eng Part A. 2013 May;19(9-10):1209-22
pubmed: 23216113
Cell Transplant. 2015;24(1):37-48
pubmed: 24069942
Mol Endocrinol. 2014 Dec;28(12):2038-48
pubmed: 25361392
Metabolism. 2000 Feb;49(2):264-9
pubmed: 10690956
J Biol Chem. 2009 Nov 27;284(48):33509-20
pubmed: 19755420
Acta Diabetol. 2016 Oct;53(5):683-91
pubmed: 26923700
Nat Rev Endocrinol. 2017 May;13(5):268-277
pubmed: 27834384
Sci Rep. 2017 Oct 19;7(1):13558
pubmed: 29051567
Development. 2012 Aug;139(16):2833-43
pubmed: 22833471
Transplant Proc. 2010 Sep;42(7):2662-5
pubmed: 20832565
Diabetes. 2017 Feb;66(2):426-436
pubmed: 27864307
Nat Med. 2000 May;6(5):568-72
pubmed: 10802714
World J Transplant. 2017 Apr 24;7(2):117-128
pubmed: 28507914
PLoS One. 2012;7(7):e40741
pubmed: 22808248
Endocr J. 2014;61(7):647-54
pubmed: 24681780
J Autoimmun. 2007 Mar-May;28(2-3):134-42
pubmed: 17383157
Diabetes. 2012 Apr;61(4):866-76
pubmed: 22362173
Diabetes Obes Metab. 2017 Sep;19 Suppl 1:124-136
pubmed: 28880471
Curr Stem Cell Res Ther. 2014;9(5):396-400
pubmed: 25012744
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7964-9
pubmed: 15899968
Hepatology. 2018 Oct;68(4):1589-1603
pubmed: 29394503
Circ Res. 2008 Jul 18;103(2):194-202
pubmed: 18556575
Islets. 2017 Nov 2;9(6):150-158
pubmed: 29111856
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10137-42
pubmed: 24982174
Curr Diab Rep. 2011 Oct;11(5):364-74
pubmed: 21789599
Cell Reprogram. 2010 Dec;12(6):655-64
pubmed: 21108535
J Biol Chem. 2009 May 1;284(18):12246-57
pubmed: 19265200
Cell Metab. 2014 Mar 4;19(3):498-511
pubmed: 24561261
Diabetes. 2004 Apr;53(4):963-70
pubmed: 15047611
Endocr Rev. 2010 Jun;31(3):343-63
pubmed: 20164242
J Biol Chem. 2003 Aug 22;278(34):31950-7
pubmed: 12775714
Blood. 2006 Aug 1;108(3):915-21
pubmed: 16861344
Cell Transplant. 2011;20(11-12):1805-15
pubmed: 21396165
Hepatology. 2007 Sep;46(3):898-905
pubmed: 17705277
Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H480-7
pubmed: 15277191
PLoS One. 2014 Feb 04;9(2):e87812
pubmed: 24504462
Tissue Eng Part A. 2016 Feb;22(3-4):375-85
pubmed: 26871862
Sci Rep. 2017 Apr 10;7(1):770
pubmed: 28396600
Stem Cells. 2017 May;35(5):1233-1245
pubmed: 28100035
J Transplant. 2011;2011:252387
pubmed: 21876779
Dev Biol. 2010 Nov 1;347(1):216-27
pubmed: 20807526
Curr Biol. 2003 Jun 17;13(12):1070-4
pubmed: 12814555
Am J Transplant. 2013 Jun;13(6):1429-40
pubmed: 23601171
Diabetes. 2015 Apr;64(4):1284-98
pubmed: 25392241
Ups J Med Sci. 2016 May;121(2):81-95
pubmed: 27124642
Diabetes. 2014 Jan;63(1):3-11
pubmed: 24357688
Diabetes. 2011 Jul;60(7):1946-54
pubmed: 21617177

Auteurs

Irit Meivar-Levy (I)

The Sheba Regenerative Medicine, Stem Cell and Tissue Engineering Center, Sheba Medical Center, Tel Hashomer, Israel. irit.meivar-levy@sheba.health.gov.il.
Dia-Cure, Institute of Medical Scientific Research Acad. Nicolae Cajal, University Titu Maiorescu, Bucharest, Romania. irit.meivar-levy@sheba.health.gov.il.

Fatima Zoabi (F)

The Sheba Regenerative Medicine, Stem Cell and Tissue Engineering Center, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gil Nardini (G)

Department of Plastic Surgery, Sheba Medical Center, Tel Hashomer, Israel.

Eugenia Manevitz-Mendelson (E)

The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.

Gil S Leichner (GS)

The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.

Oranit Zadok (O)

The Sheba Regenerative Medicine, Stem Cell and Tissue Engineering Center, Sheba Medical Center, Tel Hashomer, Israel.

Michael Gurevich (M)

The Organ Transplantation Division, Schneider Children Medical Center, Petach Tikvah, Israel.

Eytan Mor (E)

The Organ Transplantation Division, Schneider Children Medical Center, Petach Tikvah, Israel.

Simona Dima (S)

Dia-Cure, Institute of Medical Scientific Research Acad. Nicolae Cajal, University Titu Maiorescu, Bucharest, Romania.
Center of Excellence in Translational Medicine - Fundeni Clinical Institute, Bucharest, Romania.
Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania.

Irinel Popescu (I)

Dia-Cure, Institute of Medical Scientific Research Acad. Nicolae Cajal, University Titu Maiorescu, Bucharest, Romania.
Center of Excellence in Translational Medicine - Fundeni Clinical Institute, Bucharest, Romania.
Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania.

Aviv Barzilai (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.

Sarah Ferber (S)

The Sheba Regenerative Medicine, Stem Cell and Tissue Engineering Center, Sheba Medical Center, Tel Hashomer, Israel.
Dia-Cure, Institute of Medical Scientific Research Acad. Nicolae Cajal, University Titu Maiorescu, Bucharest, Romania.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Shoshana Greenberger (S)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
The Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH